Effects of Black Tea on Cardiovascular Disease in the Mauritian Population

NCT00114907 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2007-04-06

No results posted yet for this study

Summary

It is proposed to investigate the association between consumption of black tea and various selective fasting blood serum and urine biomarkers in a Mauritian population with ischaemic heart diseases. This study, the first of its kind, will provide clinical data on the potential prophylactic propensities of Mauritian black tea against cardiovascular disease, which remains one of the major health threats to the Mauritian population.

Conditions

  • Cardiac Disease

Interventions

BEHAVIORAL

Consumption of black tea

Sponsors & Collaborators

  • Mauritius Research Council

    collaborator OTHER
  • Cardiac Centre, Pamplemousses

    collaborator OTHER
  • London South Bank University

    collaborator OTHER
  • University of Mauritius

    lead OTHER

Principal Investigators

  • Theeshan Bahorun, PhD · University of Mauritius

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Completion
2005-06-30

Countries

  • Mauritius

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00114907 on ClinicalTrials.gov